Skip to content.
|
Skip to navigation
Site Map
Accessibility
Contact
Search Site
Advanced Search…
The Cancer Letter
Sections
Home
Publications
About Us
Advertising
The Cancer Letter Archive
The Clinical Cancer Letter Archive
BRR Archive
TCL In The News
FAQ
Special Reports
Personal tools
Log in
You are here:
Home
→
PARP Inhibitors The Talk Of ASCO
Navigation
Home
Publications
About Us
Advertising
The Cancer Letter Archive
The Clinical Cancer Letter Archive
BRR Archive
TCL In The News
FAQ
Contact Us
Special Reports
Top Headlines
PARP Inhibitors The Talk Of ASCO
Subscribe or renew subscription
Google Ad Links
Send this page to somebody
Fill in the email address of your friend to send an email with the address.
Address info
Send to
(Required)
The e-mail address to send this link to.
From
(Required)
Your email address.
Comment
A comment about this link.
Log in
Login Name
Password
Cookies are not enabled. You must
enable cookies
before you can log in.
Forgot your password?
Top Headlines
«
July 2010
»
Su
Mo
Tu
We
Th
Fr
Sa
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
2010-07-02 00:00
00:00-00:00 Three Cooperative Groups To Combine Statistical Center Operations
2010-07-09 00:00
00:00-00:00 In Exit Interview, Niederhuber Says Clinical Trials System Must Refocus To Emphasize Translational Studies
2010-07-15 00:00
00:00-00:00 Harold Varmus Takes NCI Helm With No Promises, No Clichés
00:00-00:00 Prominent Duke Scientist Claimed Prizes He Didn't Win, Including Rhodes Scholarship
2010-07-23 00:00
12:00-12:00 Note to Cancer Letter Subscribers for Friday, July 23
14:40-14:40 The Potti Scandal: Biostatisticians Send Letter to Varmus, Lancet Oncology Expresses Concern
Recent entries:
The Potti Scandal: Biostatisticians Send Letter to Varmus, Lancet Oncology Expresses Concern
Note to Cancer Letter Subscribers for Friday, July 23
Prominent Duke Scientist Claimed Prizes He Didn't Win, Including Rhodes Scholarship
Harold Varmus Takes NCI Helm With No Promises, No Clichés
In Exit Interview, Niederhuber Says Clinical Trials System Must Refocus To Emphasize Translational Studies
More...
Categories:
FDA
(
16
)
Medicare
(
4
)
NCI
(
43
)
cancer prevention
(
4
)
cancer screening
(
19
)
cancer treatment
(
16
)
drug development
(
33
)
legislation
(
6
)
news makers
(
3
)
oncology profession
(
12
)
policy issues
(
31
)
research funding
(
41
)
Google Ads
Powered by Plone CMS, the Open Source Content Management System
This site conforms to the following standards:
Section 508
WCAG
Valid XHTML
Valid CSS
Usable in any browser